Overview

Maxon™ synthetic absorbable sutures are prepared from polyglyconate, a copolymer of glycolic acid and trimethylene carbonate.

The advanced extrusion process of the molecule of polyglyconate gives the suture:

  • Excellent in-vivo strength retention
  • Excellent knot tying security

Maxon™ synthetic absorbable sutures are indicated for use in general soft tissue approximation and/or ligation, including use in pediatric cardiovascular tissue, where growth is expected to occur, and in peripheral vascular surgery. They are not indicated for use in adult cardiovascular tissue, ophthalmic surgery, microsurgery, and neural tissues.

PRODUCT INFORMATION
Structure Monofilament
Suture Type Long-Term Absorbable
Composition Polyglyconate Copolymer of Glycolic Acid and Trimethylene Carbonate
Coating Uncoated
Colour Green, Clear
Tensile Strength 6 weeks
Absorption Profile 180 days
Sizes 7 - 0 to 1
Indications Maxon™ and Maxon™ CV suture is indicated for use as absorbable suture in general soft tissue approximation and/or ligation, including use in pediatric cardiovascular tissue, where growth is expected to occur, and in peripheral vascular tissue. Maxon™ and Maxon™ CV suture is not indicated for use in adult cardiovascular tissue, ophthalmic surgery, microsurgery and neural tissue.
Contraindications The use of this suture is contraindicated in patients with known sensitivities or allergies to its components. This suture, being absorbable, should not be used where extended approximation of tissue is required or for fixation of permanent cardiovascular prostheses or synthetic grafts.
Box Quantities 1, 2 or 3 dozen

Maxon™ codes can be identified with codes beginning with:

888666, 88866, CMM, SMM, GMM, VMM, GMMT

Specifications